Mouse Genome Editing Core Unit

Home | Research & Innovation | Scientific Programmes | Biotechnology Programme | Mouse Genome Editing Core Unit

Technicians

  • Beatriz Escobar
  • Carmen Gómez
  • Melani Margullón
  • Jaime Muñoz
  • Patricia Prieto
  • Pierfrancesco Vargiu

Cancer encompasses an extensive range of highly intricate diseases. Alterations in the genetic and epigenetic makeup of tumour cells result in the acquisition of “malignant” characteristics, allowing them to elude normal physiological regulation. Techniques involving genome editing and transgenesis are employed to faithfully replicate these changes in mice, creating indispensable animal models essential for comprehending and improving cancer treatment. Tumour cells engage with various bodily systems, including the immune, cardiovascular, and lymphatic systems, influencing tumour growth, invasion, and expansion. Behavioural elements such as diet or smoking also influence cancer development. To unravel this intricate complexity, dependable in vivo models are imperative, replicating cancer features in a comprehensive “whole body” setting. The precise, targeted, and controlled manipulation of the mouse genome, utilising cutting-edge genome editing tools, facilitates the development of genetic mouse models crucial for deciphering the molecular mechanisms of tumour formation and for preclinically validating advanced and more effective cancer therapies.

Publications

Up

CNIO
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.